Circulating tumor DNA dynamics and response to immunotherapy in colorectal cancer-Reference-Cited by-同舟云学术

Circulating tumor DNA dynamics and response to immunotherapy in colorectal cancer

Published:2022-03-30 Issue:5 Volume:16 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Gong Jun¹,Aguirre Francesca²,Hazelett Dennis²,Alvarez Rocio²,Zhou Lisa²,Hendifar Andrew¹,Osipov Arsen¹,Zaghiyan Karen³,Cho May⁴,Gangi Alexandra³,Hitchins Megan²

Affiliation:

1. Department of Medicine, Division of Hematology and Oncology, Samuel Oschin Comprehensive Cancer Institute, Cedars‑Sinai Medical Center, Los Angeles, CA 90048, USA

2. Department of Biomedical Sciences, Cedars‑Sinai Medical Center, Los Angeles, CA 90048, USA

3. Department of Surgery, Samuel Oschin Comprehensive Cancer Institute, Cedars‑Sinai Medical Center, Los Angeles, CA 90048, USA

4. Division of Hematology and Oncology, Department of Medicine, University of California, Irvine, CA 92697, USA

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference24 articles.

1. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer;André;N Engl J Med,2020

2. FDA Approval summary: Pembrolizumab for the treatment of microsatellite instability-high solid tumors;Marcus;Clin Cancer Res,2019

3. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): An open-label, multicentre, phase 2 study;Overman;Lancet Oncol,2017

4. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer;Overman;J Clin Oncol,2018

5. Safety and efficacy of anti-PD-1 antibody dostarlimab in patients (pts) with mismatch repair-deficient (dMMR) solid cancers: Results from GARNET study;Andre;J Clin Oncol,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developments and current status of cell‐free DNA in the early detection and management of hepatocellular carcinoma;Journal of Gastroenterology and Hepatology;2023-11-21

2. POLE-Mutant Colon Cancer Treated with PD-1 Blockade Showing Clearance of Circulating Tumor DNA and Prolonged Disease-Free Interval;Genes;2023-05-08

3. Predictive biomarkers of colon cancer immunotherapy: Present and future;Frontiers in Immunology;2022-11-22

4. Blood-based biomarkers for immune-based therapy in advanced HCC: Promising but a long way to go;Frontiers in Oncology;2022-10-31